Search

everythinglearnresearchcommunity

for

Search:↓

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride may improve prostate cancer treatment outcomes.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Ashwagandha serum improves hair health and quality of life in people with hair loss.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Finasteride boosts stem cell signals for hair growth.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.